Ad is loading...
IDTA
Price
$0.56
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
PXMBF
Price
$3.50
Change
-$0.00 (-0.00%)
Updated
May 16 closing price
Ad is loading...

IDTA vs PXMBF

Header iconIDTA vs PXMBF Comparison
Open Charts IDTA vs PXMBFBanner chart's image
Identa
Price$0.56
Change-$0.00 (-0.00%)
Volume$5.9K
CapitalizationN/A
PAXMAN AB
Price$3.50
Change-$0.00 (-0.00%)
Volume$600
CapitalizationN/A
IDTA vs PXMBF Comparison Chart
Loading...
View a ticker or compare two or three
VS
IDTA vs. PXMBF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDTA is a Hold and PXMBF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (IDTA: $0.56 vs. PXMBF: $3.50)
Brand notoriety: IDTA and PXMBF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IDTA: 141% vs. PXMBF: 100%
Market capitalization -- IDTA: $1.42M vs. PXMBF: $56.48M
IDTA [@Medical Specialties] is valued at $1.42M. PXMBF’s [@Medical Specialties] market capitalization is $56.48M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDTA’s FA Score shows that 1 FA rating(s) are green whilePXMBF’s FA Score has 0 green FA rating(s).

  • IDTA’s FA Score: 1 green, 4 red.
  • PXMBF’s FA Score: 0 green, 5 red.
According to our system of comparison, IDTA is a better buy in the long-term than PXMBF.

Price Growth

IDTA (@Medical Specialties) experienced а +12.00% price change this week, while PXMBF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
PXMBF($56.5M) has a higher market cap than IDTA($1.42M). IDTA YTD gains are higher at: 344.444 vs. PXMBF (25.000). PXMBF has higher annual earnings (EBITDA): 21.8M vs. IDTA (218K). PXMBF has more cash in the bank: 29.1M vs. IDTA (329K). IDTA has less debt than PXMBF: IDTA (822K) vs PXMBF (16.3M). PXMBF has higher revenues than IDTA: PXMBF (160M) vs IDTA (1.32M).
IDTAPXMBFIDTA / PXMBF
Capitalization1.42M56.5M3%
EBITDA218K21.8M1%
Gain YTD344.44425.0001,378%
P/E Ratio14.60N/A-
Revenue1.32M160M1%
Total Cash329K29.1M1%
Total Debt822K16.3M5%
FUNDAMENTALS RATINGS
IDTA: Fundamental Ratings
IDTA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
16
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
36

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DCTH9.390.16
+1.73%
Delcath Systems
TNC86.23-0.96
-1.10%
Tennant Company
PR14.80-0.38
-2.50%
Permian Resources Corp
VTAK0.47-0.03
-6.00%
Catheter Precision
MNMD7.76-0.63
-7.51%
Mind Medicine (MindMed)

PXMBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PXMBF has been loosely correlated with IDTA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PXMBF jumps, then IDTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PXMBF
1D Price
Change %
PXMBF100%
N/A
IDTA - PXMBF
53%
Loosely correlated
N/A
ANSLF - PXMBF
37%
Loosely correlated
N/A
IOBCF - PXMBF
30%
Poorly correlated
N/A
BLOZF - PXMBF
24%
Poorly correlated
+8.08%
BIAF - PXMBF
20%
Poorly correlated
-1.50%
More